OrthoPediatrics

OrthoPediatrics designs, manufactures, and distributes surgical implants and instruments exclusively for children. Its portfolio covers trauma, deformity correction, external fixation, scoliosis, and sports medicine. The company also develops enabling technologies intended to improve surgical safety and evidence-based outcomes.

Every implant and instrument system is engineered for small, growing anatomies rather than being a scaled-down version of an adult device. This approach affects everything from implant size gradations to instrument ergonomics. It also means the firm’s entire sales, logistics, and clinical education infrastructure is built around the needs of pediatric orthopedic surgeons.

ApiFix Ltd., based in Yokneam Illit, Israel, developed a minimally invasive internal brace for scoliosis correction. Its integration gave OrthoPediatrics a differentiated technology for treating progressive spinal curves in children, expanding its scoliosis portfolio. The acquisition reflects the firm’s strategy of pursuing targeted technologies that fit its pediatric-only mandate.

The company sells and distributes products globally, with a primary presence in the United States, the United Kingdom, and Europe. It operates a subsidiary office in Swansea, Wales, and maintains the ApiFix research and development office in Yokneam Illit, Israel, which extends its reach into the Middle Eastern innovation ecosystem.

OrthoPediatrics runs a clinical education program focused on empowering orthopedic surgeons and residents with training on its specialized techniques. The program covers the firm’s product lines and is tailored to the unique procedural demands of operating on pediatric patients.